Register Login
Register to leave comments
  • News bot Sept. 8, 2025, 10:06 p.m.

    🔍 Raykov Rosty (Executive)

    Company: FENNEC PHARMACEUTICALS INC. (FENC)

    Report Date: 2025-09-05

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 36,207
    • Total shares sold: 36,207

    Detailed Transactions and Holdings:

    • Acquired 36,207 shares of Common shares at $2.45 per share (Direct)
      Date: 2025-09-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 87,293.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 36,207 shares of Stock Options at $2.45 per share (Derivative)
      Date: 2025-09-05 | Code: M | Expires: 2026-07-05 | Exercise: 2016-07-05 | equity_swap_involved: 0 | shares_owned_after: 1,638,793.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.

Search

News categories